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Abstract 52 
Background: Vitamin C and inorganic nitrate have been linked to enhanced nitric oxide (NO) 53 
production and reduced oxidative stress. Vitamin C may also enhance the conversion of nitrite 54 
into NO.  55 
Aims: We investigated the potential acute effects of vitamin C and inorganic nitrate co-56 
supplementation on blood pressure (BP) and peripheral vascular function. The secondary aim 57 
was to investigate whether age modified the effects of vitamin C and inorganic nitrate on these 58 
vascular outcomes.  59 
Methods: Ten younger (age 18-40y) and ten older (age 55-70y) healthy participants were 60 
enrolled in a randomised double-blind crossover clinical trial. Participants ingested a solution 61 
of potassium nitrate (7 mg/kg body weight) and/or vitamin C (20 mg/kg body weight) or their 62 
placebos. Acute changes in resting BP and vascular function (post-occlusion reactive 63 
hyperemia [PORH], peripheral pulse wave velocity [PWV]) were monitored over a 3-hour 64 
period. 65 
Results: Vitamin C supplementation reduced PWV significantly (vitamin C: -0.70±0.31m/s; 66 
vitamin C placebo: +0.43±0.30m/s; P=0.007). There were significant interactions between age 67 
and vitamin C for systolic, diastolic, and mean arterial BP (P = 0.02, P = 0.03, P = 0.02, 68 
respectively), with systolic, diastolic and mean BP decreasing in older participants and diastolic 69 
BP increasing in younger participants following vitamin C administration. Nitrate 70 
supplementation did not influence BP (systolic: P = 0.81; diastolic: P = 0.24; mean BP: P = 71 
0.87) or vascular function (PORH: P = 0.05; PWV: P = 0.44) significantly in both younger and 72 
older participants.  However, combined supplementation with nitrate and vitamin C reduced 73 
mean arterial BP (-2.6 mmHg, P = 0.03) and decreased PWV in older participants (PWV:  -2.0 74 
m/s, P = 0.02). 75 
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Conclusions: The co-administration of a single dose of inorganic nitrate and vitamin C lowered 76 
diastolic BP and improved PVW in older participants.  Vitamin C supplementation improved 77 
PWV in both age groups but decreased systolic and mean BP in older participants only.  78 
5 
 
Introduction  79 
High intakes of fruit and vegetables are associated with reduced risk of cardiovascular diseases 80 
(1, 2). Several bioactive components of fruits and vegetables, including flavonoids, vitamin C 81 
and inorganic nitrate (𝑁𝑂3
−),  are proposed to be responsible for these cardio-protective effects 82 
(3-5). Vitamin C may slow the progression of atherosclerosis (6) via several mechanisms 83 
including enhanced nitric oxide (NO) synthesis and endothelial integrity, synthesis of collagen 84 
and improved arterial structural morphology, reduced circulating concentrations of cholesterol 85 
and triglycerides, reduced formation of atherogenic, oxidized low density lipoproteins (LDL) 86 
and epigenetic regulation of gene expression (7, 8). However, inconsistent, and largely null, 87 
results from large RCTs have challenged the hypothesis that vitamin C has protective effects 88 
on cardiovascular outcomes (9).  89 
Inorganic 𝑁𝑂3
− is the stable end-product of NO metabolism. Once considered as an inert ion, 90 
the recent discovery of the  𝑁𝑂3
−- nitrite ( 𝑁𝑂2
−)-NO pathway as an important contributor to 91 
systemic NO synthesis has revived interest in the physiological roles of  𝑁𝑂3
−  and stimulated 92 
further research into the effects of dietary  𝑁𝑂3
− intake on cardiovascular and metabolic 93 
outcomes (10, 11). In particular, some foods such as beetroot and green leafy vegetables (e.g. 94 
rocket, lettuce, or spinach) are rich in 𝑁𝑂3
− (12, 13) and their ingestion contributes substantially 95 
to the  𝑁𝑂2
− and NO in the circulation (14, 15).   96 
Individually, vitamin C and inorganic 𝑁𝑂3
−, have beneficial effects on cardiovascular outcomes 97 
(16-19) and the possibility of a mechanistic interaction between vitamin C and  𝑁𝑂3
− and  𝑁𝑂2
−  98 
was recognized more than 40 years ago, when vitamin C was used to block the conversion of 99 
 𝑁𝑂3
− and  𝑁𝑂2
− into N-nitroso compounds (NOCs) (20, 21). These NOCs were regarded as an 100 
important step in the initiation of gastric carcinogenesis and, therefore, attenuating their 101 
formation was viewed as highly advantageous (22). The purported mechanisms of the 102 
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beneficial effects of vitamin C included removal of  𝑁𝑂2
− by converting it into NO and, 103 
therefore, preventing the formation of NOCs (22). Several studies have also reported the 104 
possibility of interaction between vitamin C and the 𝑁𝑂3
−- 𝑁𝑂2
−-NO pathway (23-25). Vitamin 105 
C may enhance the reaction of deoxyhemoglobin (HbFe2+) with  𝑁𝑂2
− in an acidic environment 106 
which liberates NO (𝑁𝑂2
− + HbFe2+ + H+ → NO + HbFe3+ + OH−) and increases the NO pool 107 
(14, 26).  108 
In the present study, we hypothesized that the acute co-administration of inorganic 𝑁𝑂3
− and 109 
vitamin C would elicit a greater increase in  𝑁𝑂2
− formation and biomarkers of NO activity 110 
(e.g. cyclic guanosine monophosphate [cGMP]) than either agent alone. Therefore, the 111 
combined supplement was expected to produce greater improvements in blood pressure (BP), 112 
skin microvascular blood flow and pulse wave velocity (PWV).  113 
During ageing, inflammation and oxidative stress are the primary drivers of endothelial 114 
dysfunction (27) and may modulate the vascular effects of inorganic 𝑁𝑂3
− (28, 29). In addition, 115 
age-related changes in the oral microflora (30), which is integral to the conversion of 𝑁𝑂3
− 116 
into 𝑁𝑂2
−, may lower NO production and contribute to the impairment of endothelial-117 
dependent vasodilatory responses whereas endothelial-independent responses do not appear to 118 
be associated with age (31, 32).  Similarly, the effects of vitamin C supplementation on 119 
cardiometabolic health may differ between younger and older individuals (17).  Age-related 120 
differences in the response to vitamin C could be due to differences in oxidative stress (33) 121 
and/or to differences between younger and older individuals in the efficiency of ‘recycling’ of 122 
vitamin C (34).  Therefore, we further hypothesized that the effects of inorganic 𝑁𝑂3
− and 123 
vitamin C supplementation on cardiovascular outcomes would differ between younger and 124 
older participants.      125 
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In a crossover RCT, we investigated the acute effects of administration of vitamin C and 126 
inorganic 𝑁𝑂3
− separately, and in combination, on resting BP, vascular function and circulating 127 
biomarkers linked to the NO pathway i.e., nitrate, nitrite, cGMP, tetrahydrobiopterin (BH4) 128 
and 3-nitrotyrosine (3-NT). Further, we investigated whether age modifies the putative 129 
interactions between vitamin C and inorganic 𝑁𝑂3
− on these outcomes by studying effects of 130 
supplementation in both younger and older participants.  131 
Methods  132 
Participants  133 
The study included twenty normal weight and overweight (body mass index [BMI] range: 20.0-134 
29.9 kg/m2) younger (age: 18-40 years) and older (age: 55-70 years) healthy male and female 135 
participants (9 males, 11 females). All study visits were conducted in the Clinical Ageing 136 
Research Unit (CARU), Newcastle University, UK from November 2014 to November 2015. 137 
The trial was performed in accordance with the Declaration of Helsinki and the principles of 138 
the International Conference on Harmonization-Good Clinical Practice (ICH-GCP) guidelines. 139 
Exclusion criteria and the sample size calculation are provided in the Online Supplemental 140 
Material. The study was approved by the regional ethics committee of the East of Scotland 141 
Research Ethics Service (EoSRES) (REC reference:  14/ES/0059) and was registered with 142 
Current Controlled Trials (ISRCTN98942199).  143 
Study design and randomisation 144 
This was a Latin-square, factorial, cross-over, randomized, double-blind, placebo-controlled 145 
study. The randomization was conducted by an independent investigator outside the research 146 
team. The preparation and labelling of the solutions (inorganic 𝑁𝑂3
−, vitamin C and their 147 
placebos) were performed by the Pharmacy Department of the Newcastle upon Tyne Hospitals 148 
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NHS Foundation Trust (Royal Victoria Infirmary). Intervention agents (inorganic 𝑁𝑂3
−  or 149 
vitamin C) and the corresponding placebo solutions had the same visual characteristics i.e. 150 
identical volume, color and presentation.  151 
Nutritional supplements  152 
The active 𝑁𝑂3
− supplement provided 7 mg of potassium 𝑁𝑂3
− per kg body weight (0.1 153 
mmol/kg, dose ranged from 5.1 to 8.7 mmol) in sterile water (200 ml) while its placebo 154 
provided a matched amount of potassium chloride (7 mg per kg body weight, dose ranged from 155 
1014 to 1734). The active vitamin C supplement provided 20 mg ascorbic acid per kg body 156 
weight and its placebo provided a matched volume of 0.9% sodium chloride solution (25 ml). 157 
Participants were randomised to the following interventions: 1)  𝑁𝑂3
− supplementation (active) 158 
+ vitamin C (active); 2)  𝑁𝑂3
− supplementation (active) + vitamin C (placebo); 3)  𝑁𝑂3
− 159 
supplementation (placebo) + vitamin C (active); 4)  𝑁𝑂3
− supplementation (placebo) + vitamin 160 
C (placebo). Each participant received all four interventions in four consecutive visits and each 161 
visit was separated by a 7-day washout period. The  𝑁𝑂3
− dose corresponded to the amount 162 
ingested in 150–250 g of a  𝑁𝑂3
−-rich vegetable such as spinach, lettuce or beetroot (35). The 163 
dose of vitamin C provided in this study was 20 mg/kg i.e. 1400 mg for a 70-kg adult person. 164 
This dose was based on our observation (from a systematic review and meta-analysis of the 165 
relevant literature) that the lowest effective dose to improve vascular function was 166 
approximately 1000 mg vitamin C per day (16).   167 
Study protocol  168 
Screening visit: After an initial telephone interview, potentially eligible individuals were 169 
invited to the research unit in a fasting condition (at least 12 hours) for a screening visit at 170 
which they were given detailed information about the study and had their BMI and BP 171 
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measured. Eligible individuals were then asked to complete a written consent form to 172 
participate in the study. Additionally, a blood sample was collected for the assessment of 173 
plasma  𝑁𝑂3
− and vitamin C concentrations. At the end of that screening visit, and in 174 
preparation for each of the subsequent study visits, participants were asked to follow a 175 
low 𝑁𝑂3
−/low vitamin C run-in diet and to avoid using antibacterial mouthwash or chewing-176 
gum for two days prior to each study visit. The run-in diet ensured a standardised low  𝑁𝑂3
− 177 
and vitamin C intake by study participants. The mouthwash and chewing-gum restriction 178 
avoided any interference with the salivary conversion of  𝑁𝑂3
− into  𝑁𝑂2
−.  179 
Study visits (1, 2, 3 and 4): Participants arrived early in the morning (~8.00am) in a fasting 180 
condition (~ 12 hours). Participants were then randomized to one of the four intervention agents 181 
described above. Body weight, height and waist circumference were measured and body 182 
composition (fat free mass) was assessed by bioelectrical impedance analysis (Tanita BC420 183 
MA, Tanita Corporation, Tokyo, Japan). A cannula was then inserted in the ante-cubital vein 184 
while the participant was lying in a supine position. Blood pressure (systolic, diastolic) was 185 
measured at baseline (pre-dose administration) and then every 30 minutes after the 186 
administration of the intervention. Vascular function was assessed by laser Doppler post-187 
reactive occlusion hyperemia (PORH) and PWV at baseline and 180 min post-intervention. 188 
Blood samples were collected at 0, 30, 60, 120 and 180 minutes. During the visit, participants 189 
were asked to complete a validated food frequency questionnaire to assess their typical food 190 
intake (36). Two short questionnaires were completed to assess physical activity levels (37) 191 
and dietary 𝑁𝑂3
− intake (see online supplementary material) over the week prior to each visit. 192 
After each study session, the cannula was removed from the participants’ arm and a small 193 
breakfast was offered to the participant. Participants were asked to return to their normal eating 194 
habits during the first 5 days of the wash-out period and to follow the low  𝑁𝑂3
−/low vitamin 195 
C run-in diet for 2 days prior to their next study visit. This protocol was repeated at the second, 196 
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third and fourth (last) visits and each time the nutritional interventions were administered as 197 
dictated by the randomization order. A detailed description of the study phases and 198 
measurement protocols conducted during the study is provided in Supplemental Figure 1.  199 
Blood pressure  200 
Baseline BP was measured five times at 1-minute intervals using a semi-automated BP recorder 201 
(Dinamap V100; GE Medical Systems, Milwaukee, WI, USA). The mean of the five records 202 
was recorded as the baseline BP. Subsequently, BP was measured at 30, 60, 90, 120, 150, 180 203 
minutes after administration of the intervention. Measurements of BP were conducted whilst 204 
the participant was in a rested, supine position and readings were concealed from the 205 
participant. 206 
Cutaneous microvascular blood flow 207 
Cutaneous microvascular reactivity was measured during PORH of the forearm using laser 208 
Doppler (Moor LDF, Moor Instruments, Axminster, UK). A description of the measurement 209 
protocol is provided in the Supplemental Methods.  210 
Peripheral pulse wave velocity and arterial volume distensibility   211 
Finger and ear photoplethysmography (PPG) and ECG signals were recorded simultaneously, 212 
from which the peripheral arm PWV and arterial volume distensibility  (AVD) were obtained 213 
(38). The optical PPG probes were attached to the index finger and earlobe to record arterial 214 
pulses at the two locations. A three-electrode ECG signal was also recorded to provide a timing 215 
reference for the PPG pulses. A description of the measurement protocol is provided in the 216 
Supplemental Methods.  217 
Blood sample processing and biochemical assays 218 
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At each predetermined time point, blood samples were processed immediately after collection. 219 
Stop solution (0.25mL per 1mL of plasma) was added to blood aliquots intended for measuring 220 
plasma  𝑁𝑂3
− and  𝑁𝑂2
− concentration, as described in the Supplemental Methods. Blood 221 
samples were spun at 5000x g for 5 minutes at 4C and serum and plasma aliquots were stored 222 
immediately at -80C until analyzed. Plasma concentrations of  𝑁𝑂3
− and  𝑁𝑂2
− were analysed 223 
via chemiluminescence (Sievers NOA 280i, Analytix Ltd, Durham, UK) using a validated 224 
method (39). Vitamin C concentration in plasma was estimated using ESA CoulArray high 225 
performance liquid chromatography (HPLC; ESA Inc.). Dehydroascorbic acid (DHA) 226 
Microplate Assay Kits (Cohesion Biosciences) and cGMP Complete ELISA kits (ENZO Life 227 
Sciences Inc) were used to quantify DHA and cGMP, respectively. We analyzed plasma 228 
concentration of BH4 using Human Tetrahydrobiopterin Elisa Kit (MBS283103, 229 
MyBiosource, Inc. San Diego, USA) and 3-NT in serum using ELISA kits (ab210603, Abcam, 230 
Cambridge, USA).  231 
Statistical analysis 232 
Data were checked for normality and appropriate transformations were applied for non-233 
normally distributed data. Summary data are presented as means ± SEM. For outcomes with 234 
repeated measurements over time (BP and plasma concentrations of vitamin C, 235 
DHA, 𝑁𝑂3
−, 𝑁𝑂2
−, cGMP, BH4 and 3-NT), we calculated the area under curve (AUC) over 3 236 
hrs using the trapezoid method. The mean differences were calculated for EF outcomes (PORH 237 
index, PWV and AVD) by subtracting the baseline measurements from the measurements at 238 
the end of the visits. Linear mixed models were applied to analyse the data using Stata version 239 
13 (StataCorp LP, TX, USA). The statistical model examined the effects of each dietary agent 240 
(inorganic 𝑁𝑂3
− or vitamin C) separately and tested for a potential interaction effect (interaction 241 
between inorganic 𝑁𝑂3
− and vitamin C). In addition, the effect of age and possible interactions 242 
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between age and the other two factors were examined by including age as fixed factor in the 243 
statistical model. The statistical analysis took into consideration the factorial design and a 244 
graphical description of the analysis is presented in Supplemental Figure 4. The main effects 245 
of inorganic 𝑁𝑂3
− were investigated by comparing groups which were given  𝑁𝑂3
− with groups 246 
who were not (Nitrate + vs. Nitrate -). The main effects of vitamin C were explored by 247 
comparing groups who were given vitamin C with groups who were not (Vitamin C + vs. 248 
Vitamin C -). Fixed factors include inorganic 𝑁𝑂3
−, vitamin C (within-participant factors) and 249 
age (between-participant factor). Participants were regarded as a random factor. Due to the 250 
presence of significant interaction for certain outcomes, statistical analyses per group 251 
(inorganic 𝑁𝑂3
−, vitamin C and the combination of both interventions versus placebo) were 252 
included in Supplemental Figures 5-8. GraphPad Prism version 7 (GraphPad software, CA, 253 
USA) was used to construct the graphs.  P values < 0.05 were considered to indicate statistical 254 
significance.  255 
Results  256 
Recruitment and baseline characteristics of the participants 257 
A total of 20 participants were randomized to the interventions, ten younger (29 ± 1 years) and 258 
ten older (62 ± 1 years) participants (Supplemental Figure 9). All participants completed all 259 
four study visits. The interventions were well-tolerated and no adverse effects were reported. 260 
Baseline characteristics of the participants showed that the younger and older participants were 261 
well-matched for anthropometric variables, dietary energy intake, and inorganic  𝑁𝑂3
− and 262 
vitamin C intakes (Table 1). However, systolic, diastolic BP and mean arterial BP were 263 
significantly higher in older participants (P < 0.01).  264 
𝑵𝑶𝟑
− and  𝑵𝑶𝟐
− concentrations  265 
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Plasma  𝑁𝑂3
− and  𝑁𝑂2
− concentrations were increased significantly after inorganic 𝑁𝑂3
− (P < 266 
0.001), but not vitamin C (both P = 0.32), supplementation. No significant differences were 267 
apparent between younger and older participants for plasma  𝑁𝑂3
− (P = 0.55) or  𝑁𝑂2
− (P = 268 
0.12) concentrations in response to supplementation. Likewise, plasma  𝑁𝑂3
− and  𝑁𝑂2
− 269 
concentrations were similar when inorganic 𝑁𝑂3
− was administered alone and in combination 270 
with vitamin C (Figure 1A and 1B).  271 
Vitamin C and DHA concentrations  272 
Vitamin C supplementation significantly increased plasma vitamin C (P < 0.001) and DHA (P 273 
= 0.04) concentrations.  However, inorganic 𝑁𝑂3
−  supplementation had no significant effect 274 
on either vitamin C (P = 0.77) or DHA (P = 0.58) concentrations. In comparison with younger 275 
participants, vitamin C concentration was higher in older participants in response to 276 
supplementation (P = 0.04). However, no interactions between age, inorganic 𝑁𝑂3
−  and 277 
vitamin C supplementation were detected (Figure 1C and 1D).  278 
Systolic, diastolic and mean BP 279 
Baseline systolic, diastolic and mean arterial BP were significantly higher in older compared 280 
with younger participants (P < 0.01). There were no significant differences in systolic, diastolic 281 
and mean arterial BP between inorganic 𝑁𝑂3
− and vitamin C groups (inorganic 𝑁𝑂3
−: systolic 282 
P = 0.12; diastolic P = 0.45; mean arterial BP P = 0.10; vitamin C: systolic P = 0.39; diastolic 283 
P = 0.91; mean arterial BP P = 0.55) (Figure 2A, 3A and 4A). However, significant interactions 284 
between age and vitamin C were observed for systolic BP (Figure 2B), diastolic BP (Figure 285 
3B) and mean arterial BP (Figure 4B) (P = 0.02, P = 0.03, P = 0.02, respectively), with systolic, 286 
diastolic and mean BP decreasing in older participants and diastolic BP increasing in younger 287 
participants following vitamin C administration (Supplemental Figure 6). There was a 288 
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significant interaction between inorganic 𝑁𝑂3
− and vitamin C for diastolic BP (P = 0.05) 289 
(Figure 3C), as diastolic BP declined in response to inorganic 𝑁𝑂3
− only when administered 290 
in combination with vitamin C supplementation. Additionally, the subgroup analyses showed 291 
a significant reduction in mean BP in older adults following vitamin C (P = 0.04), inorganic 292 
𝑁𝑂3
− (P = 0.02) and combined inorganic 𝑁𝑂3
−+vitamin C (P = 0.03) supplementation 293 
(Supplemental Figure 6C). 294 
Physiological markers of vascular function 295 
Compared with control, vitamin C supplementation significantly reduced PWV (vitamin C 296 
intervention: Δ-0.70±0.31 m/s; vitamin C placebo: Δ0.43±0.30 m/s) (P = 0.007) (Figure 5B). 297 
Neither inorganic 𝑁𝑂3
− nor vitamin C supplementation improved PORH (inorganic 𝑁𝑂3
−: P = 298 
0.31; vitamin C: P = 0.73) or AVD (inorganic 𝑁𝑂3
−: P = 0.29; vitamin C: P = 0.18) (Figure 299 
5A and 5C). Combined supplementation with nitrate and vitamin C decreased PWV in older 300 
participants (PWV:  -2.0 m/s, P = 0.02) (Supplemental Figure 7B). 301 
Circulatory biomarkers  302 
Supplementation with either inorganic 𝑁𝑂3
− or vitamin C increased BH4 significantly 303 
(inorganic 𝑁𝑂3
−: P = 0.05; vitamin C: P = 0.04) and marginally reduced 3-NT concentrations 304 
(inorganic 𝑁𝑂3
−: P = 0.07; vitamin C: P = 0.06) (Figure 6A and 6B). Moreover, a non-305 
significant reduction in cGMP (P = 0.07) was observed following the inorganic 𝑁𝑂3
− 306 
intervention (Figure 6C). No significant differences were observed between age groups (BH4: 307 
P = 0.98; 3-NT: P = 0.26; cGMP: P = 0.20). Additionally, the sub-group analyses revealed a 308 
significant increase in BH4 and decrease in 3-NT concentrations following combined inorganic 309 
𝑁𝑂3
−+vitamin C supplementation in older (BH4: P = 0.01) and younger participants (3-NT: P 310 
= 0.02), respectively (Supplemental Figure 8B and 8C). 311 
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Discussion  312 
Summary of main findings  313 
In the present acute study, vitamin C supplementation reduced arterial stiffness (PWV) 314 
significantly. Interestingly, age significantly modified the acute effects of vitamin C 315 
supplementation on systolic, diastolic, and mean arterial BP, with supplementation decreasing 316 
systolic, diastolic and mean BP in older participants and increasing diastolic BP in younger 317 
participants. A beneficial interaction was observed between inorganic  𝑁𝑂3
− and vitamin C 318 
supplementation, with combined administration of supplements associated with a reduced 319 
diastolic BP and significant reduction in PVW in older participants. Lastly, each intervention 320 
increased BH4 concentrations significantly. 321 
Effects on plasma 𝑵𝑶𝟑
− and 𝑵𝑶𝟐
− 322 
Acute administration of inorganic 𝑁𝑂3
− increased the concentrations of plasma  𝑁𝑂3
− and 𝑁𝑂2
− 323 
significantly, reflecting a greater availability of substrate for NO generation via the 𝑁𝑂3
−- 𝑁𝑂2
−-324 
NO pathway. In contrast with our previous study (28), we did not observe a significant 325 
difference in plasma 𝑁𝑂3
− between younger and older participants.  Vanhatalo et al have tested 326 
the effects of beetroot juice supplementation for 10-days on plasma  𝑁𝑂3
− and 𝑁𝑂2
− and BP 327 
responses in young (18–22 yrs) and older (70–79 yrs) normotensive humans and found 328 
increased plasma concentration of  𝑁𝑂2
− and reduced systemic BP in older but not young 329 
participants (40). This disparity in findings could be related to between-study differences in the 330 
participant cohort and study design.  Specifically, in the current study we recruited normal and 331 
overweight participants (BMI 20 – 29.9 kg/m2), whereas our previous investigation involved 332 
obese individuals (BMI 30 – 40 kg/m2), receiving an oral dose of potassium nitrate immediately 333 
after the ingestion of solution containing 75g of glucose. In addition, in the current study we 334 
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did not observe any modifying effects of vitamin C on plasma concentrations of  𝑁𝑂3
− 335 
and 𝑁𝑂2
−. Given that previous in vitro and animal studies have reported a possible interaction 336 
between vitamin C and the  𝑁𝑂3
−- 𝑁𝑂2
−- NO pathway (23-25), this finding was unexpected. 337 
However, those previous studies did not examine plasma  𝑁𝑂3
− and 𝑁𝑂2
− concentrations 338 
directly, and it is possible that vitamin C does not influence the circulating concentrations of 339 
these metabolites in vivo in humans as the effects of vitamin C on this pathway may occur at 340 
an intra-cellular level. Montenegro et al  (41) have recently observed changes in plasma nitroso 341 
species (RXNO) concentrations following acute oral  𝑁𝑂2
− ingestion, which may represent a 342 
pool of potentially bioactive NO-related compounds contributing to the physiological effects 343 
of  𝑁𝑂3
− or 𝑁𝑂2
−  ingestion.  344 
Effects on plasma vitamin C and DHA 345 
As expected, plasma concentrations of vitamin C increased significantly after acute vitamin C 346 
administration. Vitamin C intake also resulted in a significantly higher plasma concentration 347 
of DHA – an oxidized product of ascorbic acid (42). However, unexpectedly, we observed that 348 
vitamin C supplementation produced larger increases in plasma vitamin C concentration in 349 
older compared with younger participants.  This contrasts the findings from a previous meta-350 
analysis, which found that, at the same intake (60 mg/d), circulating concentrations of vitamin 351 
C were approximately 25 % less among older versus younger adults (43).  The physiological 352 
basis through which older participants attained a greater plasma vitamin C concentration than 353 
younger participants following vitamin C supplementation in the present study is not clear.  354 
This does not appear to be related to differences in vitamin C intake or baseline plasma vitamin 355 
C concentrations prior to supplementation, since neither of these factors differed between 356 
young and older participants.  However, it is possible that reduced kidney function with ageing 357 
may have resulted in slower excretion of excess vitamin C in our older participants who 358 
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received the equivalent of 1440 mg vitamin C per 70 kg body mass compared with only 60 mg 359 
vitamin C in the studies reported by Brubacher et al. (43). Whilst age-related differences in 360 
vitamin C excretion could be important, previous research has suggested that vitamin C renal 361 
excretion was unaffected by age (44).  It is unlikely that the higher plasma vitamin C 362 
concentration in  older individuals was due to more rapid vitamin C absorption since the latter 363 
is  reduced in older participants (43), possibly as a consequence of a decreased activity of 364 
sodium-dependent vitamin C transporter proteins in the intestine (45). The differences in 365 
vitamin C concentrations between age groups could be potentially explained by differences in 366 
cellular utilisation of vitamin C between younger and older individuals. However, these 367 
speculations require further investigation to confirm the potential effects of ageing on the 368 
pharmacokinetic profile of vitamin C.   369 
Effects of acute supplementation with vitamin C and nitrate on BP  370 
In the present investigation, there was no evidence that acute supplementation with inorganic 371 
𝑁𝑂3
− altered BP (systolic: P = 0.81; diastolic: P = 0.24; mean BP: P = 0.87). Given the evidence 372 
from earlier studies showing BP-lowering effects of inorganic 𝑁𝑂3
− supplementation (19), this 373 
observation was unexpected.  Ashworth et al. (46) reported that the reduction in BP following 374 
inorganic 𝑁𝑂3
− supplementation is inversely related to the baseline BP of participants.  Hence, 375 
it is possible that the BP lowering effect of 𝑁𝑂3
− supplementation was diminished in our 376 
participants because of their relatively low, normotensive pre-supplementation BP. 377 
Alternatively, it is possible that the acute supplementation used here was insufficient to lower 378 
BP and that a more prolonged dosing protocol may have elicited greater BP-lowering effects 379 
(47). However, it is clear from previous studies that chronic supplementation is not essential to 380 
reduce BP with 𝑁𝑂3
− supplementation (19, 48, 49).  381 
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Vitamin C supplementation elicited different effects on BP in younger and older participants.  382 
Specifically, in older participants, vitamin C supplementation lowered both systolic and 383 
diastolic BP whereas BP tended to increase in younger participants following acute vitamin C 384 
supplementation. Previous studies have shown inconsistent effects of vitamin C 385 
supplementation on BP.  The slight increase in BP observed here in younger participants is 386 
similar to previous results reported by Magen and colleagues (50) who showed that treating 387 
hypertensive patients with vitamin C (500 mg/day) for 8 weeks increased diastolic BP by 4.2 388 
mmHg. Nevertheless, it is unclear why our younger participants and the hypertensive 389 
population studied by Magen et al (50) reacted similarly to vitamin C, and caution is therefore 390 
advised when interpreting these findings.  Two additional studies reported significant increases 391 
in diastolic BP (51, 52) with vitamin C administration but the latter two studies used a 392 
combination of vitamin C with vitamin E and folic acid (51) or with polyphenols (52). In 393 
contrast, a meta-analysis by Juraschek et al. (4) reported significant BP reduction with short-394 
term vitamin C supplementation.  Additionally, in contrast with our findings, Juraschek et al. 395 
reported significantly greater reductions in systolic BP in younger (age < 50 years: WMD: -396 
5.07, 95% CI: -7.22 to -2.92) compared with older (age > 60 years: WMD: -1.85, 95% CI: -397 
2.94 to -0.77) participants. Nearly half of the studies included in the meta-analysis by Juraschek 398 
et al. supplemented vitamin C with other micronutrients or pharmacological agents (4) whereas 399 
we supplemented with vitamin C alone or in combination with inorganic 𝑁𝑂3
−. The potential 400 
modifying effects of the substances co-administered with vitamin C on BP have not been 401 
studied systematically but it seems unlikely that such effects explain the age-dependent 402 
changes observed in our study.    403 
An important finding of this study is that there was a beneficial interaction between 404 
inorganic 𝑁𝑂3
− and vitamin C supplementation on diastolic BP i.e. the combination of agents 405 
resulted in a 1.7 mmHg reduction in diastolic BP. A plausible mechanism for this interaction 406 
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could be enhanced conversion of 𝑁𝑂2
− to NO in the presence of supplemental vitamin C and 407 
that the extra NO resulted in lower BP. However, we did not observe any difference in the 408 
plasma concentration of 𝑁𝑂2
− after inorganic 𝑁𝑂3
− + vitamin C co-supplementation compared 409 
with inorganic 𝑁𝑂3
− supplementation alone possibly because these are intra-cellular effects and 410 
are not reflected in circulating concentrations of 𝑁𝑂2
−. Moreover, this interaction was not 411 
mirrored by an increase in cGMP concentration, the secondary messenger of NO.  412 
In our study, BH4, a co-factor of endogenous NO production, increased significantly after the 413 
administration of vitamin C and inorganic 𝑁𝑂3
−. In vitro and animal studies demonstrated that 414 
vitamin C and inorganic 𝑁𝑂3
− may enhance the stability of BH4 by reducing oxidized BH3 to 415 
BH4 and/or by preventing BH4 from being oxidized by free radicals (53-55). BH4 depletion 416 
causes uncoupling of eNOS enzymes with the consequent production of superoxide free 417 
radicals instead of NO (56). BH4 supplementation may reverse endothelial dysfunction in 418 
healthy individuals and in patients with cardio-metabolic disorders (57).  419 
Effects on markers of vascular function 420 
Vitamin C significantly improved peripheral PWV in our participants. In addition, the 421 
combined inorganic 𝑁𝑂3
−+vitamin C significantly improved peripheral PWV in older 422 
participants.This is in contrast with the overall lack of effect of vitamin C supplementation on 423 
indices of arterial stiffness reported in our previous meta-analysis (58) . However, that meta-424 
analysis included only studies in which supplemental vitamin C had been given for more than 425 
2 weeks and it is possible that acute supplementation with vitamin C affects PWV. Moreover, 426 
in the statistical analysis reported in our previous meta-analysis, we pooled together data from 427 
several indices of arterial stiffness (augmentation index, compliance coefficient, distensibility 428 
coefficient and digital volume pulse, in addition to PWV) which may have obscured the 429 
positive effects, if any, of vitamin C on PWV.   430 
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Strengths and limitations  431 
Inorganic 𝑁𝑂3
− and vitamin C are abundant in human foods and are frequently co-ingested in 432 
meals. In the current study, we have demonstrated, for the first time, the potential of beneficial 433 
interaction of inorganic 𝑁𝑂3
− and vitamin C on markers of CVDs, particularly diastolic BP. 434 
The crossover Latin-square design ensures a strict within-volunteer control of factors that may 435 
affect the study outcomes such as age, body composition and health status. In the current study, 436 
we included a selected population of healthy normal/overweight population with no diseases 437 
or drug treatments that may confound our results. Moreover, our two age groups were well-438 
matched for many anthropometric, dietary and physiological variables with the exception of 439 
BP which was significantly higher in the older participants. However, there are some 440 
limitations associated with the study that need to be addressed in future clinical trials. We did 441 
not investigate the possibility of interactions of vitamin C with inorganic 𝑁𝑂3
− in the oral cavity 442 
(no saliva samples collected), stomach (expelled stomach NO was not collected) and urinary 443 
system (no urine samples collected). The increase in diastolic BP in the younger group 444 
following vitamin C supplementation was unexpected and a cautious interpretation is required 445 
for this observation until it is confirmed in future studies. Moreover, we did not use FMD and 446 
carotid-femoral PWV that are regarded as gold standard measures of endothelial function (59) 447 
and arterial stiffness (60), respectively.     448 
Conclusions  449 
Acute supplementation with a large dose of vitamin C lowered systolic and diastolic BP in 450 
older but not younger healthy participants. Furthermore, there was an interaction between 451 
inorganic 𝑁𝑂3
− and vitamin C in which inorganic 𝑁𝑂3
− lowered diastolic BP and improved 452 
PWV in older participants only when co-supplemented with vitamin C. Future studies will be 453 
needed to determine whether the effects seen here with acute supplementation are sustained in 454 
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the longer-term and, if so, to address the mechanisms and the potential sites of interactions of 455 
vitamin C and inorganic 𝑁𝑂3
−.  456 
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Table 1: Baseline characteristics of young and older participants1 630 
1Data shown as mean±SEM. 2Independent sample t test. 3MET: Metabolic Equivalent of Task, 631 
4BH4: tetrahydrobiopterin 632 
  633 
 
All Young Older 2P value 
Number  20 10 10 
 
Gender (male/female) 9/11 5/5 4/6 
 
Age (years) 46±4 29±2 62±1 0.0001 
Body mass index (kg/m2) 24.3±0.6 24.5±0.7 24.2±1 0.82 
Waist circumference (cm) 84.9±2.1 84.8±2.4 85.2±3.7 0.94 
Fat mass (kg) 18.6±1.1 18.4±1.4 18.9±1.6 0.83 
Systolic blood pressure (mmHg) 116±4 106 ±3 125±6 0.009 
Diastolic blood pressure (mmHg) 66±2 60±1 72±3 0.001 
Mean arterial pressure (mmHg) 85±3 78±2 93±4 0.002 
Energy intake (KJ/day) 12204±983 13638±1720 10769±815 0.14 
Vitamin C intake (mg/day) 170.5±20 184.5±28 156.5±28 0.48 
Nitrate intake (mg/day) 176.5±11.6 179.1±20 173.9±12 0.82 
Physical activity, METs/wk3 3440±322 3142±390 3801±533 0.31 
Plasma nitrate (µmol/L)  27.3±2 29.6±2.8 25.1±2.7 0.27 
Plasma nitrite (nmol/L) 238±24 245±43 231±23 0.78 
Plasma vitamin C (µmol/L) 56.9±4 51±7 62.4±3 0.17 
Plasma BH44 (pg/mL)  565±60 464±64 665±92 0.10 
Serum 3-nitrotyrosine (nmol/mL) 592±60 543±87 640±86 0.43 
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Figure 1: Plasma  𝑁𝑂3
− (A),  𝑁𝑂2
−  (B), vitamin C (C) and DHA (D) concentrations in young 634 
(n = 10) and older participants (n = 10) given a single dose of inorganic  𝑁𝑂3
− (7 mg/kg weight), 635 
vitamin C (20 mg/kg), both agents together, or their placebos in a factorial crossover design. 636 
Values are means ± SEMs. Data were analysed using linear mixed model. ***: P < 0.001; 637 
****: P < 0.0001. AUC: 3 hours area under curve; N+: inorganic 𝑁𝑂3
− intervention; N-: 638 
inorganic 𝑁𝑂3
− control; VC+: vitamin C intervention; VC-: vitamin C control.  639 
 640 
Figure 2: Systolic blood pressure (BP)  (A) and the age × vitamin C interaction (B) in younger 641 
(n= 10) and older participants (n= 10) given a single dose of inorganic  𝑁𝑂3
−  (7 mg/kg body 642 
weight), vitamin C (20 mg/kg) both agents combined or their placebos in a 2×2 factorial 643 
crossover design. Values are means ± SEMs. Data were analysed using linear mixed model. *: 644 
P < 0.05; **: P < 0.01.  AUC: 3 hours area under curve; N+: inorganic 𝑁𝑂3
− intervention; N-: 645 
inorganic 𝑁𝑂3
− control; VC+: vitamin C intervention; VC-: vitamin C control.  646 
 647 
Figure 3: Diastolic blood pressure (BP)  (A), the age × vitamin C interaction (B) and inorganic 648 
 𝑁𝑂3
− × vitamin C interaction (C) in younger (n= 10) and older participants (n= 10) given a 649 
single dose of inorganic  𝑁𝑂3
−  (7 mg/kg body weight), vitamin C (20 mg/kg) both agents 650 
combined or their placebos in a 2×2 factorial crossover design. Values are means ± SEMs. Data 651 
were analysed using linear mixed model. *: P < 0.05; **: P < 0.01.  AUC: 3 hours area under 652 
curve; N+: inorganic 𝑁𝑂3
− intervention; N-: inorganic 𝑁𝑂3
− control; VC+: vitamin C 653 
intervention; VC-: vitamin C control 654 
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Figure 4: Mean arterial blood pressure (BP)  (A), the age × vitamin C interaction (B) in 656 
younger (n= 10) and older participants (n= 10) given a single dose of inorganic  𝑁𝑂3
−  (7 mg/kg 657 
body weight), vitamin C (20 mg/kg) both agents combined or their placebos in a 2×2 factorial 658 
crossover design. Values are means ± SEMs. Data were analysed using linear mixed model. 659 
***: P < 0.001.  AUC: 3 hours area under curve; N+: inorganic 𝑁𝑂3
− intervention; N-: 660 
inorganic 𝑁𝑂3
− control; VC+: vitamin C intervention; VC-: vitamin C control.  661 
 662 
Figure 5: Post-occlusive reactive hyperemia (PORH) (A), pulse wave velocity (PWV) (B), 663 
and arterial volume distensibility (AVD) (C) in young (n = 10) and older participants (n = 10) 664 
given a single dose of inorganic  𝑁𝑂3
−  (7 mg/kg weight), vitamin C (20 mg/kg) alone, both 665 
combined, or their placebos in a factorial crossover design. Values are means ± SEMs. Data 666 
were analysed using linear mixed model. *: P < 0.05. N+: inorganic 𝑁𝑂3
− intervention; N-: 667 
inorganic 𝑁𝑂3
− control; VC+: vitamin C intervention; VC-: vitamin C control. 668 
 669 
 670 
Figure 6: Plasma tetrahydrobiopterin (BH4) (A) 3 nitrotyrosine (3-NT) (B) and cyclic 671 
guanosine monophosphate (cGMP) (C) concentrations in young (n= 10) and older participants 672 
(n= 10) given a single dose of inorganic 𝑵𝑶𝟑
− (7 mg/kg body weight), vitamin C (20 mg/kg) 673 
alone, both combined, or their placebos in a factorial crossover design. Values are means ± 674 
SEMs. Data were analysed using linear mixed model. *: P < 0.05. AUC: 3 hours area under 675 
curve; N+: inorganic 𝑵𝑶𝟑
− intervention; N-: inorganic 𝑵𝑶𝟑
− control; VC+: vitamin C 676 
intervention; VC-: vitamin C control. 677 
 
